Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation - Contacts and Locations

Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

This study has been completed.

Study NCT00003611. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003611

Locations


United States, Arizona
	CCOP - Scottsdale Oncology Program
	Scottsdale, Arizona, United States, 85259-5404

United States, Florida
	Mayo Clinic
	Jacksonville, Florida, United States, 32224

United States, Illinois
	CCOP - Carle Cancer Center
	Urbana, Illinois, United States, 61801
	CCOP - Illinois Oncology Research Association
	Peoria, Illinois, United States, 61602

United States, Iowa
	CCOP - Iowa Oncology Research Association
	Des Moines, Iowa, United States, 50309-1016

United States, Kansas
	CCOP - Wichita
	Wichita, Kansas, United States, 67214-3882

United States, Minnesota
	CentraCare Health Plaza
	Saint Cloud, Minnesota, United States, 56303
	Mayo Clinic Cancer Center
	Rochester, Minnesota, United States, 55905

United States, North Dakota
	Medcenter One Health System
	Bismarck, North Dakota, United States, 58501

United States, South Dakota
	CCOP - Sioux Community Cancer Consortium
	Sioux Falls, South Dakota, United States, 57104
	Rapid City Regional Hospital
	Rapid City, South Dakota, United States, 57709

Sponsors and Collaborators

North Central Cancer Treatment Group

National Cancer Institute (NCI)

Investigators


Study Chair:	Mark R. Pittelkow, MD	Mayo Clinic